In this report, we look at the ﬁndings from our latest Global Forensic Data Analytics Survey. We have analyzed the responses of some 745 executives globally who generously shared their perspectives. Through this analysis, we can see speciﬁc ways in which companies can measurably improve their legal, compliance and fraud risk programs, as well as the maturity level of their FDA capabilities.
It is an exciting time for companies as digital transformation creates new opportunities. Artiﬁcial intelligence, robotic process automation and advanced data analytics are just some of the new possibilities being explored. However, a growing digital footprint comes with additional risks.
Two risks come into sharp focus in this survey: 1) regulatory compliance, 2) data protection and data privacy. We heard from companies around the world that expressed growing concern in these areas and identiﬁed real challenges to overcome. This year’s Global Forensic Data Analytics Survey ﬁndings show that this is where Forensic Data Analytics (FDA) has a vital role to play. >>
Want to stay updated about everything related to PRIMO & developments in Risk Management? Sign up for our Newsletter.